Issue 1/2013
Content (41 Articles)
Life-course evidence of birth weight effects on bone mass: systematic review and meta-analysis
J. Martínez-Mesa, M. C. Restrepo-Méndez, D. A. González, F. C. Wehrmeister, B. L. Horta, M. R. Domingues, A. M. B. Menezes
Erratum to: Life-course evidence of birth weight effects on bone mass: systematic review and meta-analysis
J. Martínez-Mesa, M. C. Restrepo-Méndez, D. A. González, F. C. Wehrmeister, B. L. Horta, M. R. Domingues, A. M. B. Menezes
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis, E. V. McCloskey, H. Johansson, C. Cooper, R. Rizzoli, J.-Y. Reginster
Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)
G. Ioannidis, J. Flahive, L. Pickard, A. Papaioannou, R. D. Chapurlat, K. G. Saag, S. Silverman, F. A. Anderson Jr, S. H. Gehlbach, F. H. Hooven, S. Boonen, J. E. Compston, C. Cooper, A. Díez-Perez, S. L. Greenspan, A. Z. LaCroix, R. Lindsay, J. C. Netelenbos, J. Pfeilschifter, M. Rossini, C. Roux, P. N. Sambrook, E. S. Siris, N. B. Watts, J. D. Adachi
Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women
S. Tanaka, T. Kuroda, M. Saito, M. Shiraki
Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study
S. Boutroy, D. Hans, E. Sornay-Rendu, N. Vilayphiou, R. Winzenrieth, R. Chapurlat
Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men
S. Verschueren, E. Gielen, T. W. O’Neill, S. R. Pye, J. E. Adams, K. A. Ward, F. C. Wu, P. Szulc, M. Laurent, F. Claessens, D. Vanderschueren, S. Boonen
A decreasing trend in fall-related hip fracture incidence in Victoria, Australia
E. Cassell, A. Clapperton
Depressive symptoms and rates of bone loss at the hip in older men
S. J. Diem, S. L. Harrison, E. Haney, J. A. Cauley, K. L. Stone, E. Orwoll, K. E. Ensrud
Relationship between use of antidepressants and risk of fractures: a meta-analysis
V. Rabenda, D. Nicolet, C. Beaudart, O. Bruyère, J.-Y. Reginster
Dairy foods and osteoporosis: an example of assessing the health-economic impact of food products
F. J. B. Lötters, I. Lenoir-Wijnkoop, P. Fardellone, R. Rizzoli, E. Rocher, M. J. Poley
Cost-effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial
C. E. Wyers, P. L. M. Reijven, S. M. A. A. Evers, P. C. Willems, I. C. Heyligers, A. D. Verburg, S. van Helden, P. C. Dagnelie
Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight
J. T. Schousboe, M. Gourlay, H. A. Fink, B. C. Taylor, E. S. Orwoll, E. Barrett-Connor, L. J. Melton III, S. R. Cummings, K. E. Ensrud
Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study
H. P. Bhattoa, E. Nagy, C. More, J. Kappelmayer, A. Balogh, E. Kalina, P. Antal-Szalmas
Vitamin D status is associated with physical performance: the results of three independent cohorts
E. Sohl, R. T. de Jongh, A. C. Heijboer, K. M. A. Swart, E. M. Brouwer-Brolsma, A. W. Enneman, C. P. G. M. de Groot, N. van der Velde, R. A. M. Dhonukshe-Rutten, P. Lips, N. M. van Schoor
Vitamin D2 from light-exposed edible mushrooms is safe, bioavailable and effectively supports bone growth in rats
M. S. Calvo, U. S. Babu, L. H. Garthoff, T. O. Woods, M. Dreher, G. Hill, S. Nagaraja
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
N. Freemantle, C. Cooper, A. Diez-Perez, M. Gitlin, H. Radcliffe, S. Shepherd, C. Roux
Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
M. Shiraki, T. Sugimoto, T. Nakamura
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
M. R. McClung, E. M. Lewiecki, M. L. Geller, M. A. Bolognese, M. Peacock, R. L. Weinstein, B. Ding, E. Rockabrand, R. B. Wagman, P. D. Miller
Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges
D. H. Solomon, E. Mercer, S. B. Woo, J. Avorn, S. Schneeweiss, N. Treister
Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study
L. Bondo, P. Eiken, B. Abrahamsen
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice
T. Thomas, S. Horlait, J. D. Ringe, A. Abelson, D. T. Gold, P. Atlan, J. L. Lange
Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study
J.-H. Kang, J. J. Keller, H.-C. Lin
Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies
K. Sun, J. M. Liu, H. X. Sun, N. Lu, G. Ning
QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis
J. K. Lee, C. H. Lee, C. H. Choi
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
M. R. McClung, J. R. Zanchetta, A. Racewicz, C. Roux, C.-L. Benhamou, Z. Man, R. A. Eusebio, J. F. Beary, D. E. Burgio, E. Matzkin, S. Boonen, P. Delmas
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
M. R. McClung, A. Balske, D. E. Burgio, D. Wenderoth, R. R. Recker
Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia—a randomized placebo-controlled trial
R. D. Chapurlat, M. Laroche, T. Thomas, S. Rouanet, P. D. Delmas, M.-C. de Vernejoul
Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study
B. Abrahamsen, K. H. Rubin, P. A. Eiken, R. Eastell
Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: results from the HORIZON Pivotal Fracture Trial
L. Yang, A. V. Sycheva, D. M. Black, R. Eastell
Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients
S. Gamsjaeger, B. Hofstetter, E. Zwettler, R. Recker, J. A. Gasser, E. F. Eriksen, K. Klaushofer, E. P. Paschalis
The impact of dietary calcium intake and vitamin D status on the effects of zoledronate
S. Bourke, M. J. Bolland, A. Grey, A. M. Horne, D. J. Wattie, S. Wong, G. D. Gamble, I. R Reid
Balloon kyphoplasty compared to vertebroplasty and nonsurgical management in patients hospitalised with acute osteoporotic vertebral compression fracture: a UK cost-effectiveness analysis
A. Svedbom, L. Alvares, C. Cooper, D. Marsh, O. Ström
Ten-year hip fracture incidence rate trends in a large California population, 1997–2006
A. L. Adams, J. Shi, M. Takayanagi, R. M. Dell, T. T. Funahashi, S. J. Jacobsen
Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients
S. Pilz, A. Meinitzer, A. Tomaschitz, K. Kienreich, H. Dobnig, M. Schwarz, D. Wagner, C. Drechsler, C. Piswanger-Sölkner, W. März, A. Fahrleitner-Pammer
The cyclooxygenase-2 selective inhibitor NS-398 does not influence trabecular or cortical bone gain resulting from repeated mechanical loading in female mice
T. Sugiyama, L. B. Meakin, G. L. Galea, L. E. Lanyon, J. S. Price
Comment on Kanis et al.: Pitfalls in the external validation of FRAX
M. J. Bolland, A. Grey, G. Gamble, I. R. Reid
Pitfalls in the external validation of FRAX: response to Bolland et al.
J. A. Kanis, A. Oden, H. Johansson, E. McCloskey